Valneva SE (VALN) Non-Current Assets (2020 - 2026)

Valneva SE's (VALN) quarterly Non-Current Assets came in at $199.7 million in Q1 2026, down 2.74% year-on-year from $205.3 million in Q1 2025, and down 2.69% quarter-over-quarter from $205.2 million in Q4 2025.

Valneva SE (VALN) Non-Current Assets (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Non-Current Assets across 7 years of filings, most recently posting $199.7 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $199.7 million, down 2.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $199.7 million (down 2.74% YoY), and the FY2025 annual result was $205.2 million, down 4.47% from the prior year.
  • Non-Current Assets came in at $199.7 million for Q1 2026 at Valneva SE, down from $205.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $261.2 million in Q1 2022 to a low of $199.7 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $213.6 million (2024), against an average of $217.3 million.
  • Across the five-year window, Non-Current Assets slipped 24.23% in 2022 and grew 7.5% in 2024, its largest moves.
  • Valneva SE's Non-Current Assets stood at $200.7 million in 2022, then grew by 5.76% to $212.2 million in 2023, then increased by 1.22% to $214.8 million in 2024, then decreased by 4.47% to $205.2 million in 2025, then fell by 2.69% to $199.7 million in 2026.
  • The last three Non-Current Assets figures came in at $199.7 million (Q1 2026), $205.2 million (Q4 2025), and $210.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 62,953.78
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4.56 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 30.30 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.26 Bn 94.26 Bn - 39.71 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 199.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 199.70 Mn
Dec 31, 2025 205.22 Mn
Sep 30, 2025 210.31 Mn
Jun 30, 2025 212.70 Mn
Mar 31, 2025 205.32 Mn
Dec 31, 2024 214.81 Mn
Sep 30, 2024 233.92 Mn
Jun 30, 2024 212.60 Mn
Mar 31, 2024 213.57 Mn
Dec 31, 2023 212.22 Mn
Sep 30, 2023 217.59 Mn
Jun 30, 2023 218.97 Mn
Mar 31, 2023 215.39 Mn
Dec 31, 2022 200.67 Mn
Sep 30, 2022 223.38 Mn
Jun 30, 2022 236.17 Mn
Mar 31, 2022 261.16 Mn
Dec 31, 2021 264.85 Mn
Dec 31, 2020 167.80 Mn